EQUITY (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
4 Months Ended |
6 Months Ended |
9 Months Ended |
12 Months Ended |
May 22, 2026 |
Apr. 24, 2026 |
Nov. 13, 2025 |
Oct. 10, 2025 |
Oct. 07, 2025 |
Jul. 25, 2025 |
Jun. 03, 2025 |
May 26, 2025 |
Mar. 13, 2025 |
Mar. 06, 2025 |
Nov. 24, 2024 |
Oct. 29, 2024 |
Oct. 23, 2024 |
Jul. 18, 2024 |
Jul. 15, 2024 |
May 22, 2024 |
May 07, 2024 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 07, 2023 |
Jun. 30, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Sep. 30, 2025 |
Sep. 30, 2024 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
275,000,000
|
|
|
275,000,000
|
275,000,000
|
|
275,000,000
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000,000
|
|
|
25,000,000
|
25,000,000
|
|
25,000,000
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
$ 0.0001
|
|
$ 0.0001
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
0
|
0
|
|
0
|
|
| Issuance of shares |
10,364,476
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid in capital issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,154,250
|
$ 6,017,700
|
|
|
$ 22,674,963
|
$ 15,076,556
|
|
|
| Market price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 373,250,000
|
|
|
$ 373,250,000
|
$ 373,250,000
|
|
|
|
| Net proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 426,750,033
|
206,400,015
|
|
|
| Stock issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,674,963
|
15,076,556
|
|
|
| Proceds from private placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 26,750,000
|
|
|
|
$ 26,750,000
|
|
|
|
| Cash fee percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.50%
|
|
|
|
| Sale of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
1,000,000
|
|
|
|
| Sale of stock, price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 26.75
|
|
|
$ 26.75
|
$ 26.75
|
|
|
|
| Offerring costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,154,250
|
|
|
|
| Sales agent commissions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
668,750
|
|
|
|
| Legal costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
| Deferred offering costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 385,500
|
|
|
$ 385,500
|
385,500
|
|
|
|
| Proceeds from offerring costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,595,750
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
$ 0.0001
|
|
$ 0.0001
|
|
| Weighted average shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
632,698
|
|
1,184,300
|
|
| Shares stock option exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,140,000
|
|
944,000
|
|
| Exercise prices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.17
|
|
$ 2.55
|
|
| Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,650,000
|
$ 2,284,500
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 23.63
|
|
|
$ 23.63
|
$ 23.63
|
|
$ 10.31
|
$ 2.34
|
| Weighted average fair value per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25.79
|
|
|
|
| 2023 Stock Option Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock available for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
679,440
|
|
|
|
|
|
| Share based compensation description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This
amount may increase annually on January 1 each year beginning on January 1, 2026 to January 1, 2035, by an amount equal to the
lesser of (i) 5% of the Common Stock outstanding on the last day of the immediately preceding calendar year and (ii) such smaller
number of shares of Common Stock as determined by the board of directors (the “Board”) or a committee of the Board. The
shares of Common Stock subject to the 2025 Equity Plan may be authorized, but unissued, or reacquired shares
|
|
|
|
|
|
| Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Market price per share |
|
$ 24.48
|
$ 33.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units, granted |
|
36,603
|
423,766
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
| Restricted stock units, fair value |
|
$ 896,041
|
$ 14,280,914
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units, percent |
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
100.00%
|
100.00%
|
|
|
|
| Restricted stock units remaining vest, percent |
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,446,444
|
|
|
|
| RSU unrecognized compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17,547,026
|
|
|
$ 17,547,026
|
$ 17,547,026
|
|
|
|
| Restricted Stock Units (RSUs) [Member] | One Third Grant Date Anniversary [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units, one-third vested |
|
|
392,694
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) [Member] | Grant Date Anniversary [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units, one-third vested |
|
|
11,872
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) [Member] | Six Month Grant Date Anniversary [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units, one-third vested |
|
|
|
|
|
|
19,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2025 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock available for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,750,000
|
|
|
|
|
|
| Common stock available for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,126,412
|
|
|
7,126,412
|
7,126,412
|
|
|
|
| 2023 Stock Option Plans [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,316,300
|
|
|
|
|
| Restricted stock units, granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
811,117
|
|
|
|
|
| Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
$ 26.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Market price per share |
|
|
|
|
$ 47.11
|
|
|
|
|
|
$ 24.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceds from private placement |
|
|
|
|
|
|
|
|
|
|
$ 60,000,048
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants term |
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash fee percentage |
|
|
|
5.00%
|
|
|
|
|
|
|
6.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non accountable expense allowance percentage |
|
|
|
|
|
|
|
|
|
|
1.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal expenses |
|
|
|
$ 200,000
|
|
|
|
|
|
|
$ 175,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of common stock |
|
|
|
|
8,490,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2025 ATM Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock offering price |
|
|
|
|
|
$ 400,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lead Managing Underwriter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
63,000
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
3,888,889
|
|
|
9,490,767
|
8,824,183
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
105,882
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid in capital issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
$ 32,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised |
|
|
|
|
|
|
|
|
|
|
|
|
105,882
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average shares |
|
|
|
|
|
|
|
|
|
338,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares stock option exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
445,000
|
266,000
|
|
|
2,140,000
|
904,000
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
$ 26.97
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiry date |
|
|
|
|
|
|
|
|
Mar. 13, 2035
|
Mar. 06, 2035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares vested stock option |
|
|
|
|
|
|
|
|
765,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vested stock option |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 580,494
|
$ 17,098,546
|
|
|
| Common Stock [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise prices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.00
|
$ 3.00
|
|
|
| Common Stock [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise prices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.50
|
$ 1.50
|
|
|
| Common Stock [Member] | Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
2,500,002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
2,500,002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Lead Managing Underwriter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
63,000
|
|
|
|
|
|
|
|
|
|
|
|
| Market price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25.00
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,091,424
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
$ 28.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares vested stock option |
|
|
|
|
|
|
|
|
55,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock Two [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
$ 28.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiry date |
|
|
|
|
|
|
|
|
Mar. 13, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares vested stock option |
|
|
|
|
|
|
|
|
5,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,562,500
|
|
|
|
|
|
|
|
|
| Price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.00
|
|
|
|
|
|
|
|
|
| Proceeds from issuance initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,250,000
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,000,000.0
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
179,375
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
| Additional paid in capital issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,538,405
|
| IPO [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
179,375
|
|
|
|
|
|
|
|
|
|
| Over-Allotment Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
384,375
|
|
|
|
|
|
|
|
|
| Proceeds from issuance initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,537,500
|
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,400,000
|
|
|
|
|
|
|
|
|
|
| Over-Allotment Option [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
158,823
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
317,646
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 5,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 4,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
317,646
|
|
|
|
|
|
|
|
|
|
|
|
|
| July 2024 Firm Commitment Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900,000
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900,000
|
|
|
|
|
|
|
|
|
|
|
| Market price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 20.00
|
|
|
|
|
|
|
|
|
|
|
| July 2024 Firm Commitment Public Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900,000
|
|
|
|
|
|
|
|
|
|
|
| Warrant issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
450,000
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18,000,000
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 16,100,000
|
|
|
|
|
|
|
|
|
|
|
| July 2024 Follow On Overallotment Warrants [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67,500
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
135,000
|
|
|
|
|
|
|
|
|
|
|
| July 2024 Follow on Overallotment Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
135.0000
|
|
|
|
|
|
|
|
|
|
|
| October 2024 Follow On Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
2,117,646
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 17.00
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
2,117,646
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
$ 36,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| October 2024 Follow On Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
2,117,646
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
1,058,823
|
|
|
|
|
|
|
|
|
|
|
|
|
| October 2024 Follow On Over Allotment Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 21.25
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant expiry |
|
|
|
|
|
|
|
|
|
|
|
|
Oct. 29, 2029
|
|
|
|
|
|
|
|
|
|
|
|
|
| October 2024 Follow On Over Allotment Option [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
15,882
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised |
|
|
|
|
|
|
|
|
|
|
|
|
15,882
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceds from private placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 404,000,000
|
|
|
|
| Private Placement [Member] | Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceds from private placement |
|
|
|
$ 378,500,000
|
|
|
|
|
|
|
$ 55,122,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceds from private placement , gross |
|
|
|
|
$ 400,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] | May 2025 Placement Agency Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal expenses |
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| May 2025 Private Placement [Member] | Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
|
$ 99,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Market price per share |
|
|
|
|
|
|
|
$ 27.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceds from private placement |
|
|
|
|
|
|
|
$ 105,000,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash fee percentage |
|
|
|
|
|
|
|
5.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of common stock |
|
|
|
|
|
|
|
3,888,889
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|